The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-chloro-4-(4-methylpiperazin-1-yl)benzofuro[3,2-d]pyrimidine ID: ALA1093180
Cas Number: 489402-96-2
PubChem CID: 2063135
Max Phase: Preclinical
Molecular Formula: C15H15ClN4O
Molecular Weight: 302.76
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(c2ncnc3c2oc2ccc(Cl)cc23)CC1
Standard InChI: InChI=1S/C15H15ClN4O/c1-19-4-6-20(7-5-19)15-14-13(17-9-18-15)11-8-10(16)2-3-12(11)21-14/h2-3,8-9H,4-7H2,1H3
Standard InChI Key: VUWKQWOFKSEXGA-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
18.1105 -0.9687 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8768 -1.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4420 -2.3482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2426 -2.1567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4751 -1.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9069 -0.7674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8094 -2.7532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1081 0.0084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1069 -0.8169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8200 -1.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8182 0.4200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5317 0.0120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5366 -0.8169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3264 -1.0685 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3185 0.2727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8075 -0.3942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6275 -0.3034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9596 0.4535 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4656 1.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6473 1.0265 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3954 0.4196 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3 4 1 0
12 11 2 0
11 8 1 0
12 13 1 0
4 5 1 0
5 6 1 0
1 2 1 0
13 14 1 0
14 16 1 0
15 12 1 0
4 7 1 0
15 16 2 0
1 6 1 0
16 17 1 0
8 9 2 0
17 18 2 0
2 3 1 0
18 19 1 0
9 10 1 0
19 20 2 0
20 15 1 0
17 1 1 0
10 13 2 0
8 21 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 302.76Molecular Weight (Monoisotopic): 302.0934AlogP: 2.78#Rotatable Bonds: 1Polar Surface Area: 45.40Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.33CX LogP: 2.77CX LogD: 2.50Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.69Np Likeness Score: -1.34
References 1. Cramp S, Dyke HJ, Higgs C, Clark DE, Gill M, Savy P, Jennings N, Price S, Lockey PM, Norman D, Porres S, Wilson F, Jones A, Ramsden N, Mangano R, Leggate D, Andersson M, Hale R.. (2010) Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists., 20 (8): [PMID:20299215 ] [10.1016/j.bmcl.2010.02.097 ] 2. Savall BM, Gomez L, Chavez F, Curtis M, Meduna SP, Kearney A, Dunford P, Cowden J, Thurmond RL, Grice C, Edwards JP.. (2011) Tricyclic aminopyrimidine histamine H4 receptor antagonists., 21 (21): [PMID:21920744 ] [10.1016/j.bmcl.2011.08.014 ] 3. Savall BM, Chavez F, Tays K, Dunford PJ, Cowden JM, Hack MD, Wolin RL, Thurmond RL, Edwards JP.. (2014) Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists., 57 (6): [PMID:24495018 ] [10.1021/jm401727m ]